Admission Date:  [**2189-9-25**]       Discharge Date:  [**2189-12-18**]  Date of Birth:   [**2189-9-25**]       Sex:  M  Service:  NEONATOLOGY  HISTORY OF PRESENT ILLNESS:  Baby boy [**Known lastname 53965**], his first name is [**Name (NI) **], is an 1180 gram baby boy [**Name2 (NI) **] at 27 and 1/7 weeks gestational age who was admitted to the Neonatal Intensive Care Unit for management of prematurity.
Betamethasone was administered at that time.
Intrapartum antibiotics were administered for preterm labor and unknown GBS status.
The infant cried at delivery with resuscitation and required facial CPAP and free flow oxygen for respiratory distress and central cyanosis.
Initial physical examination revealed a nondysmorphic infant with an intact palate, bilateral red reflex, moderate nasal flaring and retractions with decreased breath sounds bilaterally, regular cardiac rate and rhythm with no murmur.
He remained on CPAP until day of life six, when he was weaned to nasal cannula.
However, after having increased apnea of prematurity he returned to CPAP on day of life 12, but was able to be subsequently weaned off of CPAP into room air by day of life 18.
[**Known lastname **] was started on caffeine for presumed apnea of prematurity on day of life one.
He has not required volume or vasopressor support.
Fluids, electrolytes and nutrition:  [**Known lastname **] was initially NPO and received total parenteral nutrition for the first week of life while enteral feeds were advanced without incident.
He is receiving ferrous sulfate (concentration of 25 mg per ml) at 0.6 ml po q daily.
He is also receiving multivitamins as Vi-Daylin at 1 ml po q day.
Due to the clinical signs and otolaryngology findings of gastroesophageal reflux, he was also started on Ranitidine at a dose of 2 mg per kilogram per dose, which equals 7 mg PO every eight hours and he is on Metoclopramide or Reglan at approximately .1 mg per kilogram per dose, which equals a total dose of 0.3 mg po q 8.
He did receive a packed red blood cell transfusion on [**2189-10-15**] for a hematocrit of 25.
[**Known lastname **] was also started on phototherapy on his third day of life for a bilirubin of 6.5, which was his peak bilirubin.
Phototherapy was discontinued on day of life 10.
He was maintained on Ampicillin and Gentamycin for 48 hours until blood cultures were negative.
He had four examinations while in Neonatal Intensive Care Unit.
He received his vaccinations.
He has received dose one of hepatitis B vaccine on [**2189-11-13**] and dose two one month later on [**2189-12-18**].
He has also received dose one of DtAP and HIB on [**2189-11-23**] and dose one of IPV and Pneumococcal 7-valent conjugant vaccine or Prevnar on [**2189-11-25**].
He also received Synagis for RSV prophylaxis during this season and he received his first dose on [**2189-11-28**].
He will need to have Synagis administered on a monthly basis throughout the RSV season, which is considered to be through [**2190-2-18**].
Medications:      (a)ferrous sulfate (concentration 25 mg per ml) at 0.6 ml po q day, which is approximately 4 mg per kilogram per day of elemental iron;      (b)Vi-Daylin 1 ml po q day;      (c)Metoclopramide or Reglan at 0.3 mg po q 8, which is approximately 0.1 mg per kilogram per dose; and      (d)Ranitidine or Zantac at 7 mg po q 8, which is approximately 2 mg per kilogram per dose.
Immunizations received, again hepatitis B dose one on [**2189-11-13**], dose two [**2189-12-18**].
Immunizations recommended: Synagis RSV prophylaxis should be considered from [**Month (only) 359**] through [**Month (only) 547**] for infants who meet of any of the following three criteria, (1)[**Month (only) **] at less then 32 weeks, (2)[**Month (only) **] between 32 and 35 weeks with two or three of the following; day care during RSV season, smoker in the household, neuromuscular disease, airway abnormalities or school age siblings, or (3) with chronic lung disease.
Influenza immunizations should be considered annually in the fall for preterm infants with chronic lung disease once they reach six months of age.
Before this age the family and other caregivers should be considered for immunization against influenza to protect the infant.
